Cargando…
A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)()
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817724/ https://www.ncbi.nlm.nih.gov/pubmed/35135671 http://dx.doi.org/10.1016/j.therap.2022.01.014 |
| _version_ | 1784645700364009472 |
|---|---|
| author | Castan, Maxime Damin-Pernik, Marlène Thiéry, Guillaume Page, Dominique Smadja, David M. Bertoletti, Laurent |
| author_facet | Castan, Maxime Damin-Pernik, Marlène Thiéry, Guillaume Page, Dominique Smadja, David M. Bertoletti, Laurent |
| author_sort | Castan, Maxime |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8817724 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88177242022-02-07 A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)() Castan, Maxime Damin-Pernik, Marlène Thiéry, Guillaume Page, Dominique Smadja, David M. Bertoletti, Laurent Therapie Letter to Editor Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2022 2022-01-31 /pmc/articles/PMC8817724/ /pubmed/35135671 http://dx.doi.org/10.1016/j.therap.2022.01.014 Text en © 2022 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to Editor Castan, Maxime Damin-Pernik, Marlène Thiéry, Guillaume Page, Dominique Smadja, David M. Bertoletti, Laurent A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)() |
| title | A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)() |
| title_full | A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)() |
| title_fullStr | A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)() |
| title_full_unstemmed | A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)() |
| title_short | A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)() |
| title_sort | case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after ad26.cov2.s vaccine (janssen/johnson & johnson)() |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817724/ https://www.ncbi.nlm.nih.gov/pubmed/35135671 http://dx.doi.org/10.1016/j.therap.2022.01.014 |
| work_keys_str_mv | AT castanmaxime acasereportofvaccineinducedimmunethrombocytopeniaandthrombosissyndromeafterad26cov2svaccinejanssenjohnsonjohnson AT daminpernikmarlene acasereportofvaccineinducedimmunethrombocytopeniaandthrombosissyndromeafterad26cov2svaccinejanssenjohnsonjohnson AT thieryguillaume acasereportofvaccineinducedimmunethrombocytopeniaandthrombosissyndromeafterad26cov2svaccinejanssenjohnsonjohnson AT pagedominique acasereportofvaccineinducedimmunethrombocytopeniaandthrombosissyndromeafterad26cov2svaccinejanssenjohnsonjohnson AT smadjadavidm acasereportofvaccineinducedimmunethrombocytopeniaandthrombosissyndromeafterad26cov2svaccinejanssenjohnsonjohnson AT bertolettilaurent acasereportofvaccineinducedimmunethrombocytopeniaandthrombosissyndromeafterad26cov2svaccinejanssenjohnsonjohnson AT castanmaxime casereportofvaccineinducedimmunethrombocytopeniaandthrombosissyndromeafterad26cov2svaccinejanssenjohnsonjohnson AT daminpernikmarlene casereportofvaccineinducedimmunethrombocytopeniaandthrombosissyndromeafterad26cov2svaccinejanssenjohnsonjohnson AT thieryguillaume casereportofvaccineinducedimmunethrombocytopeniaandthrombosissyndromeafterad26cov2svaccinejanssenjohnsonjohnson AT pagedominique casereportofvaccineinducedimmunethrombocytopeniaandthrombosissyndromeafterad26cov2svaccinejanssenjohnsonjohnson AT smadjadavidm casereportofvaccineinducedimmunethrombocytopeniaandthrombosissyndromeafterad26cov2svaccinejanssenjohnsonjohnson AT bertolettilaurent casereportofvaccineinducedimmunethrombocytopeniaandthrombosissyndromeafterad26cov2svaccinejanssenjohnsonjohnson |